Related to these El-Habr and his co-workers have demonstrated that the accumulation of gamma-hydroxybutyrate (by-product of GABA in central nervous system) and the related SSADH downregulation contribute to a less aggressive phenotype in glioblastoma cases. The gene discussed is ALDH5A1; the disease is glioblastoma.